COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,755 Articles (22,502 medRxiv, 8,253 bioRxiv)

Most recent first Previous |  Page 1526: Articles 15251-15260  | Next

Optimal use of COVID19 Ag-RDT screening at border crossings to prevent community transmission: a modeling analysis
Chevalier, J. M., Sy, K. T. L., Girdwood, S. J., Khan, S., Albert, H., Toporowski, A., Hannay, E., Carmona, S., Nichols, B. E.
10.1101/2021.04.26.21256154 — Posted: 2021-04-28
Effectiveness of portable air filtration on reducing indoor aerosol counts: preclinical observational trials
Lee, J., Rounds, M., McGain, F., Schofield, R., Skidmore, G., Wadlow, I., Kevin, K., Stevens, A., Marshall, C., Irving, L., Kainer, M., Buising, K., Monty, J.
10.1101/2021.04.26.21256152 — Posted: 2021-04-28 Discussion: Onsite
Building Back Better after COVID-19: a systematic scoping review of wicked problems affecting developed countries and implications for global governance
van Kessel, R., Wong, B. L. H.
10.1101/2021.04.26.21256126 — Posted: 2021-04-28
The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout
Zaqout, A., Daghfal, J., Alaqad, I., Hussein, S., Aldushain, A., Almaslamani, M., Abukhattab, M., Omrani, A. S.
10.1101/2021.04.26.21256087 — Posted: 2021-04-28
COVID-19 vaccine willingness and cannabis use histories
Spechler, P. A., Stewart, J. L., Kuplicki, R., the Tulsa 1000 Investigators, , Paulus, M. P.
10.1101/2021.04.26.21256109 — Posted: 2021-04-28
Professionals' views on the mental health problems and vulnerability of children and young people during the early phase of the COVID-19 pandemic
Edbrooke-Childs, J., Labno, A., Cortina, M. A., Gilleard, A., Hayes, D., Yoon, Y., Dalton-Locke, C., Johnson, S., Simpson, A., Vera San Juan, N., Brooks-Hall, E., Mental Health Policy Research Unit
10.1101/2021.04.26.21256103 — Posted: 2021-04-28
Forecasting COVID-19 disease cases using the SARIMA-NNAR hybrid model
Demir, I., Kirisci, M.
10.1101/2021.04.26.21256108 — Posted: 2021-04-28
Reopening California: Seeking Robust, Non-Dominated COVID-19 Exit Strategies
Nascimento de Lima, P., Lempert, R., Vardavas, R., Baker, L., Ringel, J., Rutter, C. M., Ozik, J., Collier, N.
10.1101/2021.04.26.21256105 — Posted: 2021-04-28
Physician Perceptions of Surveillance: Wearables, Apps, and Bots for COVID-19
Linares, A. R., Bramstedt, K. A., Chilukuri, M. M., Doraiswamy, P. M.
10.1101/2021.04.26.21256102 — Posted: 2021-04-28
Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana
Quashie, P. K., Mutungi, J. K., Dzabeng, F., Oduro-Mensah, D., Opurum, P. C., Tapela, K., Udoakang, A. J., WACCBIP COVID-19 Team, , Asante, I., Paemka, L., Kumi-Ansah, F., Quaye, O., Amoako, E., Armah, R., Kilba, C., Boateng, N. A., Ofori, M. F., Kyei, G. B., Bediako, Y., Ndam, N. T., Abugri, J., Ansah, P., Ampofo, W. K., Mutapi, F., Awandare, G. A.
10.1101/2021.04.25.21256067 — Posted: 2021-04-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).